Market Access UK’s next pricing and access scheme to last for 7 years Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.
News Five indications added to Pharmacy First prescribing scheme Some pharmacists in England can now prescribe drugs for acne, migraines, scabies, ear infections, and rhinitis under the Pharmacy First scheme.
News Netcompany claims NHS contract to help digitise screening Denmark's Netcompany has been awarded a five-year, £215m contract from NHS England to build the digital infrastructure for adult screening programmes.
News England close to eliminating hep C thanks to treatment drive England is on track to be one of the first countries in the world to eliminate hepatitis C, thanks to a national diagnosis and treatment programme.
News UK postcode lottery ends for 'life-changing' cystinosis drug Patients in England with rare disease cystinosis will soon be able to access a drug that has been available in other UK nations for up to three years
Patients Progress with England’s Single National Formulary after a ye... Leela Barham digs deeper into the progress update from NHS England in July 2026.
News Astellas pays $285m for Audax cancer drug, and other deals Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.